COMPARISON OF BEDTIME INSULIN GLARGINE VERSUS TWICE-DAILY NPH AMONG INNER CITY ETHNIC MINORITY TYPE 2 DIABETIC PATIENTS UNCONTROLLED ON BEDTIME NPH AND ORAL AGENTS

被引：0
|
作者：
Hsia, S. H. [1 ]
机构：
[1] Charles R Drew Univ Med & Sci, Los Angeles, CA 90059 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2010年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
520
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [31] Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
    Quinzler, Renate
    Ude, Miriam
    Franzmann, Alexandra
    Feldt, Sandra
    Schuessell, Katrin
    Leuner, Kristina
    Mueller, Walter E.
    Dippel, Franz-Werner
    Schulz, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (01) : 24 - 32
  • [32] Replacement of NPH Insulin with Insulin Glargine Provided Significantly Better Glycemic Control in Patients with Type 2 Diabetes Uncontrolled on NPH Plus Oral Antihyperglycemic Drugs or Short-Acting Insulin
    Glinkina, Irina
    Shestakova, Marina
    DIABETES, 2011, 60 : A619 - A619
  • [33] With which dose of NPH insulin to start at bedtime? Study in a cohort of 1006 patients with type 2 diabetes and failure of oral antidiabetic drugs
    Mertes, B.
    Goedde, S.
    Egidi, G.
    Uebel, T.
    Kramer, G.
    Kuniss, N.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S129 - S130
  • [34] Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
    Janka, HU
    Kliebe-Frisch, C
    Plewe, G
    Schweitzer, MA
    Riddle, MC
    Yki-Jarvinen, H
    DIABETES CARE, 2005, 28 (02) : 254 - 259
  • [35] Efficacy and Safety of Insulin Glargine vs. NPH Insulin in Subjects With Type 2 Diabetes Mellitus Uncontrolled on Oral Agents: A Pooled Analysis of RCT Data
    Bolli, Geremia B.
    Porcellati, Francesca
    Lin, Jay
    Wang, Edward
    Lucidi, Paolo
    Fanelli, Carmine G.
    DIABETES, 2012, 61 : A265 - A265
  • [36] The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    Riddle, MC
    Rosenstock, J
    Gerich, J
    DIABETES CARE, 2003, 26 (11) : 3080 - 3086
  • [37] Treatment satisfaction with a basal insulin added to oral agents versus twice-daily premixed insulin alone in patients with type 2 diabetes
    Bradley, C
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Janka, HU
    DIABETES, 2005, 54 : A304 - A304
  • [38] Comparison of twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) with once-daily insulin glargine (GLA) in patients with type 2 DM on oral antidiabetic agents
    Raskin, P
    Rojas, P
    Allen, E
    DIABETES, 2004, 53 : A143 - A143
  • [39] A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: Subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study
    Fonseca, V
    Bell, DS
    Berger, S
    Thomson, S
    Mecca, TE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (05): : 274 - 280
  • [40] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    E. Lau
    A. Salem
    J. C. N. Chan
    W. Y. So
    A. Kong
    M. Lamotte
    A. Luk
    Cost Effectiveness and Resource Allocation, 17
12345